Table 2 Comparison of antimicrobial susceptibilities of clinical isolates of carbapenem resistant Acinetobacter baumannii and carbapenem resistant Acinetobacter nosocomialis
| Â | Resistance, n (%) | ||
|---|---|---|---|
Antimicrobial agent | A. baumannii(n=71) | A. nosocomialis(n=64) | pvalue |
Amikacin | 68(95.8) | 30(46.9) | <0.001 |
Gentamicin | 68(95.8) | 54(84.4) | 0.038 |
Ceftazidime | 69(97.2) | 14(21.9) | <0.001 |
Cefepime or cefpirome | 49(69.0) | 13(20.3) | <0.001 |
Ampicillin/sulbactam | 43(60.6) | 27(42.2) | 0.039 |
Piperacillin/tazobactam | 56(78.9) | 42(65.6) | 0.12 |
Ciprofloxacin | 69(97.2) | 4(6.2) | <0.001 |
Colistin | 1(1.4) | 29(45.3) | <0.001 |
Tigecycline | 6(8.2) | 0(0) | 0.03 |